TY - JOUR
T1 - Early access experience with VPRIV®
T2 - Recommendations for 'core data' collection
AU - Hughes, Derralynn A.
AU - Al-Sayed, Moeen
AU - Belmatoug, Nadia
AU - Bodamer, Olaf
AU - Böttcher, Tobias
AU - Cappellini, Maria
AU - Cohen, Ian J.
AU - Eagleton, Terence
AU - Elstein, Deborah
AU - Giraldo, Pilar
AU - Jones, Simon
AU - Kaplinsky, Chaim
AU - Lund, Allan
AU - Machaczka, Maciej
AU - Mengel, Eugen
AU - Pastores, Gregory M.
AU - Rosenbaum, Hanna
AU - Sjo, Malvin
AU - Tiling, Nikolaus
AU - Tsaftaridis, Panagiotis
AU - Zimran, Ari
AU - Weinreb, Neal
N1 - Funding Information:
Neil Weinreb has research grants from Genzyme and Shire, is on the speakers bureau for Genzyme Shire and is on Scientific Advisory Boards and has received honoraria from Genzyme (the Gaucher Registry), Shire (the therapeutic goals taskforce), and Pfizer/Protalix.
Funding Information:
Maciej Machaczka has received travel reimbursement, honoraria and research support from Genzyme Corporation, Actelion Pharmaceuticals and Shire HGT.
Funding Information:
Olaf Bodamer has received research funding from Shire and honoraria for lectures.
PY - 2011/8/15
Y1 - 2011/8/15
UR - http://www.scopus.com/inward/record.url?scp=79960837392&partnerID=8YFLogxK
U2 - 10.1016/j.bcmd.2010.10.015
DO - 10.1016/j.bcmd.2010.10.015
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 21146428
AN - SCOPUS:79960837392
SN - 1079-9796
VL - 47
SP - 140
EP - 142
JO - Blood Cells, Molecules, and Diseases
JF - Blood Cells, Molecules, and Diseases
IS - 2
ER -